This page contains a Flash digital edition of a book.
26 DRUG DISCOVERY AND DEVELOPMENT


for Stem Cell Terapies intend to develop,” said consortium co- director Sue O’Shea, a professor of cell and developmental biology at the Medical School.


In the months and years ahead, donated embryos will be used to create cell lines that carry the genes responsible for myotonic dystrophy, Huntington’s disease, Rett syndrome, spinal muscular atrophy and Tay-Sachs disease, for example.


“Tis announcement puts the University of Michigan at the very forefront of stem cell research,” said Dr Eva L Feldman, director of the U-M’s A Alfred Taubman Medical Research Institute.


Disease-specific human embryonic stem cell lines


University of Michigan joins a small handful of US universities that are creating disease-specific human embryonic stem cell lines.


L’Université du Michigan rejoint un petit nombre d’universités américaines pour créer des lignées de cellules souches embryonnaires humaines et spécifiques à la maladie.


Die Universität von Michigan verbindet eine kleine Handvoll US-Universitäten, die krankheitsspezifische menschliche embryonalen Stammzelllinien erstellen.


R


esearchers at the University of Michigan (UM) in the US have created the state’s first


human embryonic stem cell lines that carry the genes responsible for inherited disease. Te achievement will enable scientists here to study the onset and progression of genetic disorders and to search for new treatments. With this accomplishment, the UM joins a small handful of US universities that are creating disease-specific human embryonic stem cell lines. Te two new lines are named UM9-1 and UM11-1.


Above Gary Smith removes a rack containing vials that hold frozen human embryos donated to the U-M Consortium for Stem Cell Therapies. Photograph Courtesy Scott Soderberg/U-M Photo Services.


www.scientistlive.com


“All our efforts are finally starting to bear fruit,” said Gary Smith, co- director of the U-M Consortium for Stem Cell Terapies and leader of the cell-line derivation project. “Creating disease-specific human embryonic stem cell lines has been a central goal of the consortium since it was formed two years ago, and now we’ve passed that milestone.”


UM9-1 carries the genetic defect that causes haemophilia B, a hereditary condition in which the blood does not clot properly. UM11-1 carries the gene responsible for Charcot- Marie-Tooth disease, a hereditary neurological disorder characterised by a slowly progressive degeneration of the muscles in the foot, lower leg and hand.


Donated embryos If embryos are created for reproductive purposes but are found to be unsuitable for that use because they carry disease, Michigan law allows those embryos to be donated for research instead of discarding them. At that stage of development, the donated embryos consist of a cluster of cells about the size of the period at the end of this sentence.


“UM9-1 and UM11-1 are the first of many disease-specific human embryonic stem cell lines that researchers at the U-M Consortium


“We will be one of the few institutions in the country to be creating embryonic stem cell lines targeted at understanding and treating specific inherited diseases,” Feldman said. “Tese stem cell lines hold so much promise for medical science, and for this reason, they will be of tremendous interest to researchers around the world.”


Te consortium will distribute UM9-1 and UM11-1 samples to researchers across campus and to collaborators statewide. In addition, UM researchers intend to submit the lines to the US National Institutes of Health for inclusion in the national registry of human embryonic stem cell lines that are eligible for federal research funding.


UM9-1 and UM11-1 would be the only lines on the federal registry that carry the genes for haemophilia B and Charcot-Marie-Tooth disease. Tere are currently three disease-specific lines on the federal registry, which contains 91 human embryonic stem cell lines.


UM9-1 and UM11-1 are the second and third human embryonic stem cell lines created by UM consortium researchers. Te first line, UM4-6, was announced in October and was derived from a genetically normal five-day-old embryo created for reproductive purposes but no longer


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44